CBDOO at your service
Have a question? 06 70 73 89 02
🔞 Not for sale to under 18s
🔥 -20% with code 420 🌱 *excluding accessories and gummies
Have a question? 06 70 73 89 02
Today, we take a look at the difference between CBX and CBDX (or CBD-X). One is an acronym for cannabioxepane, a cannabinoid with curious properties discovered in 2011, the other stands for Cannabinoid Xtrem, a new blend of cannabinoids, of which there are more and more since the last ban in June 2024.
Without further ado, here's a precise definition of the two "molecules".
CBX is a relatively recent discovery, dating back to 2011. It was the subject of a scientific analysis published in 2015. This new minor cannabinoid is the fruit of research into Cannabis sativa, which has already led to the isolation of over a hundred compounds.
CBX was first identified in a study carried out on Carmagnola. A variety of textile hemp, naturally producing relatively high levels of CBD (between 4 and 8% on average) and low levels of THC (1%). Its name comes directly from a locality in the metropolitan city of Turin. It is one of the oldest varieties of Italian hemp, a close cousin of the "Bolognese", "Toscana" and "Ferrarese" varieties.
According to the study, CBX is a rare and structurally unique cannabinoid. It belongs to a family of biphenyl cannabinoids with a unique tetracyclic structure. This structure is partially aromatized, based on two linked benzene rings, which makes it similar to a terpene or CBDV and very different from CBD and THC.
While its structure may have aroused scientific curiosity, the same cannot be said for its effects. Indeed, the study concluded that CBX had no interaction with CB1 and CB2 receptors, nor with TRPA1 receptors, which play a role in modulating pain and inflammation, and thatit exhibited no psychotropic activity.
This is rather bad news for this newcomer, because in the absence of effects, pharmacological interest in it is limited. As you probably know, it's above all these interactions with the endocannabinoid system and TRPs that are currently being studied and researched.
Once again, as with HPE CBD, we'd be hard-pressed to answer this question. It'sa blend of cannabinoids and terpenes, playing on the entourage effect developed to replace the former derivatives now banned, such as THCP or HHCPO.
Nevertheless, sellers are not revealing anything about its composition, and we don't know which terpenes or cannabinoids are used to make the product.
According to the sites that market it, its supposed effects are :
However, we would point out that no information is provided on the exact composition of the mixture, so these effects appear to be highly speculative, entirely hypothetical and of course have no real scientific basis.
What's more, we find it quite interesting that this molecule is proposed as a replacement for THCP, and that nothing is said about any psychoactivity. We recall in passing that THCP is a minor cannabinoid quite similar to THC, and that its psychoactive properties were very real.
Although scientifically interesting for its unique structure, little scientific interest has been shown in CBX. Its lack of binding to CB1 and CB2 receptors, nor to TRPA1, distances it from current scientific research, which is focused on cannabinoids that have demonstrated pharmacological or recreational interest.
In any case, unless an unexpected discovery is made, it is highly unlikely that CBX-based products will be marketed in the years to come.
As you know, research is expensive - no money, no research. On the other hand, people are increasingly interested in the naturally beneficial and recreational potential of cannabinoids.
This is why the range of products based on mixtures of cannabinoids and terpenes, or on artificially-generated cannabinoids, is constantly growing and renewing itself with each ban.
While CBX is unlikely to be found in CBD shops, CBDx comes in a wide range of products. These include flowers, resins, gummies, vapes and e-liquids...
In short, CBX is a scientifically intriguing cannabinoid with no immediate application, while CBDX represents an opportunistic market response to changing regulations. Both are totally legal for the time being, despite the lack of research into them. And there's a reason for this. In France, as in most of Europe, CBD and its derivatives are classified as dietary supplements, and as such they join the long list of products, sometimes sold in pharmacies, whose real interest and benefits are often questioned by scientists, in the same way that vitamin mixtures are said to be useless or even dangerous[1 ; 2].
Nevertheless, as the French Minister of Health reminded us on France Inter when HHC was banned, this type of product "fills a hole in the market "[3]. A hole left by a banned but known product, with certain proven beneficial effects, to the benefit of products whose effects are as obscure as they are potentially dangerous.
Inflammatory skin diseases such as eczema and psoriasis affect millions of people worldwide. Redness, itching, flaking... These chronic conditions can impair quality of life and often require long-term, sometimes restrictive, treatment. While conventional medicine relies mainly on skin creams based on [...].
Cannabidiol (CBD) is an increasingly popular natural remedy, particularly for its anti-inflammatory, anti-anxiety and pain-relieving properties, all without the psychotropic effects of THC (cannabis). With this growing popularity, in addition to the classic flowers, oils and resins, a multitude of [...]
The supply of legal CBD is constantly evolving. Just a few weeks after the ban on HHC, new products have appeared on the shelves. THCP, THCV and the one we're going to talk about here: H4CBD. What's its history? What are its effects? What are the benefits and [...]
